Tag: Ugur Sahin

BioNTech to buy UK-based tech firm InstaDeep for AI-powered drug discovery

Raghuram Kadari- January 11, 2023

German biotechnology company BioNTech has agreed to acquire 100% of the remaining InstaDeep shares for an upfront consideration of around £362 million in cash and ... Read More

FDA grants EUA for Omicron-adapted Covid-19 vaccine for children below five

Raghuram Kadari- December 9, 2022

Pfizer and BioNTech have received the US Food and Drug Administration (FDA) emergency use authorization (EUA) for their Omicron BA.4/BA.5-adapted bivalent Covid-19 vaccine for children ... Read More

BioNTech to launch construction of mRNA-based vaccine facility in Africa

pallavi123- October 27, 2021

BioNTech revealed plans to launch the construction of a manufacturing plant for mRNA-based vaccines in the African Union mid-next year. The German biotech company said ... Read More

UK authorizes Pfizer and BioNTech’s BNT162b2 Covid-19 vaccine

pharmanewsdaily- December 2, 2020

The UK has given a temporary authorization for emergency use for the BNT162b2 Covid-19 vaccine candidate developed by Pfizer and BioNTech. The emergency use authorization ... Read More